Talon Therapeutics, Inc. (HNAB)' Product Candidate Marqibo(R) to be Assessed by Oncologic Drug Advisory Committee (ODAC) on March 21, 2012 With a PDUFA Date of May 13, 2012
2/3/2012
More...
|
Watson Pharmaceuticals, Inc. (WPI) Provides Update on Generic Lidoderm(R) Application
2/3/2012
More...
|
Molecular Insight Pharmaceuticals, Inc. (MIPI) Presents Human Data Demonstrating Detection of Metastatic Prostate Cancer
2/3/2012
More...
|
GENFIT Corp. (ALGFT) Release: The GFT505-210-6 Study Reaches All Its Efficacy Objectives With No Adverse Effects
2/3/2012
More...
|
Positive Data Presented on Athersys, Inc.' MultiStem to Treat Stroke
2/3/2012
More...
|
Exelixis, Inc. (EXEL) Release: Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma
2/3/2012
More...
|
CSL Behring Release: International Phase I Trial Results of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) Show All Pharmacokinetic Parameters Significantly Improved in Patients With Severe Hemophilia B
2/3/2012
More...
|
AEterna Zentaris (AEZS) Reports Updated Phase 1 Trial Results for AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer at ASCO GCS Meeting
2/3/2012
More...
|
OptiNose AS Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology
2/3/2012
More...
|
Acorda Therapeutics (ACOR) Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke
2/3/2012
More...
|
American Stroke Association Release: New Drug Doesn't Improve Disability Among Stroke Patients
2/3/2012
More...
|
American Stroke Association Release: Clopidogrel With Aspirin Doesn't Prevent More Small Strokes, May Increase Risk of Bleeding, Death
2/3/2012
More...
|
American Stroke Association Release: Warfarin and Aspirin are Similar in Heart Failure Treatment
2/3/2012
More...
|
Tocagen Inc. Release: Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC
2/3/2012
More...
|
American Stroke Association Release: Rare Mutations May Help Explain Aneurysm in High-Risk Families
2/3/2012
More...
|
Apricus Biosciences (APRI) Announces Acquisition of NitroMist(TM) Rights Outside North America
2/3/2012
More...
|
Bristol-Myers Squibb Company (BMY) Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibikase Therapeutics
2/3/2012
More...
|
MannKind Corporation (MNKD) Receives Commitment from the Mann Group to Acquire 31,250,000 Shares of Common Stock
2/3/2012
More...
|
BioPontis Alliance LLC Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development
2/3/2012
More...
|
Synthetic Genomics, Inc. and Integrated DNA Technologies Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology
2/3/2012
More...
|
MannKind Corporation (MNKD) Announces Pricing of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock
2/3/2012
More...
|
Cannabis Science Inc. Issues Corporate & Operations Guidance to Shareholders in Regards to Dividend, Market Potential, and Anecdotal Reports
2/3/2012
More...
|
Trading in Novo Nordisk A/S (NVO) Shares by Board Members, Executives and Associated Persons on 2 February 2012
2/3/2012
More...
|
Repros Therapeutics Inc. (RPRX) Announces the Closing of a Registered Direct Offering of Approximately $11.1 Million
2/3/2012
More...
|
SGI Takes Global Genomics Marketing Campaign to a New Level
2/3/2012
More...
|
Company Profile for JPT Peptide Technologies GmbH
2/3/2012
More...
|
Rainbow BioSciences, LLC Release: Biotech Industry on Major Upswing in 2012
2/3/2012
More...
|
DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs
2/3/2012
More...
|
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Joins OTCQX
2/3/2012
More...
|
Intellect Neurosciences, Inc. Issues Letter to Shareholders
2/3/2012
More...
|
Spherix (SPEX) Announces Registered Direct Offering of $1.15 Million
2/3/2012
More...
|
PDL BioPharma, Inc. (PDLI) Announces Exchange of Its 2.875% Convertible Senior Notes Due February 15, 2015
2/3/2012
More...
|
Cempra Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering of Common Stock
2/3/2012
More...
|
Bibby Scientific Release: Jenway Ph Electrode Range Covers Routine to Research Applications
2/3/2012
More...
|
TAP Biosystems Launches Innovative 3D Cell Culture Plate at SLAS - Novel Collagen-based Process Creates Complex 3D Cell Cultures in 3 Simple Steps
2/3/2012
More...
|
Top Medical School Uses Syngene Ingenius System to Pinpoint Microorganisms Associated With Chronic Digestive Diseases
2/3/2012
More...
|
Torrey Pines Scientific, Inc. Release: New Vibration Free Incubator Ideal for Protein Crystallography
2/3/2012
More...
|
Bayer HealthCare (BAY) Initiates Expanded Access Program for Investigational Compound Radium-223 Chloride
2/3/2012
More...
|
Alnylam Pharmaceuticals (ALNY) to Webcast Conference Call Discussing Fourth Quarter and 2011 Financial Results
2/3/2012
More...
|
AmerisourceBergen Corporation (ABC) Approves Quarterly Dividend
2/3/2012
More...
|
Biodel Inc. (BIOD) to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012
2/3/2012
More...
|
Cambrex Corporation (CBM) to Announce Fourth Quarter 2011 Financial Results on February 6, 2012
2/3/2012
More...
|
Cytokinetics, Inc. (CYTK) Reports Fourth Quarter and Year End Highlights and 2011 Financial Results
2/3/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)’s Q3 FY12 Financial Results
2/3/2012
More...
|
Gilead Sciences, Inc. (GILD) Announces Fourth Quarter and Full Year 2011 Financial Results
2/3/2012
More...
|
InterMune, Inc. (ITMN) to Release Fourth Quarter and Full Year Financial Results on February 9
2/3/2012
More...
|
Myrexis, Inc. to Hold Conference Call to Discuss Second Fiscal Quarter 2012 Financial Results
2/3/2012
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Conference Call and Webcast To Present Fourth Quarter and Year-End 2011 Financial Results
2/3/2012
More...
|
PerkinElmer, Inc. (PKI) Announces Financial Results for the Fourth Quarter of 2011
2/3/2012
More...
|
Perrigo Company (PRGO) Announces Quarterly Dividend
2/3/2012
More...
|
SurModics Inc. (SRDX) Announces Preliminary First Quarter 2012 Results
2/3/2012
More...
|
Sagent Pharmaceuticals, Inc. Sets Date and Time for Release of Fourth Quarter and Full Year 2011 Financial Results
2/3/2012
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) Reports Fourth Quarter and Full-Year 2011 Financial Results
2/3/2012
More...
|
Achillion Pharmaceuticals, Inc. Announces Executive Promotion
2/3/2012
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Appointment of Dr. Adam R. Craig as Chief Medical Officer
2/3/2012
More...
|
Affymax, Inc. (AFFY) Promotes Cynthia Smith to Vice President, Market Access and Commercial Development
2/3/2012
More...
|
MethylGene Announces the Appointment of Dr. Henry J. Fuchs to Its Board of Directors
2/3/2012
More...
|
Medicago, Inc. Announces Investment in Quebec City Pilot Production Facility
2/3/2012
More...
|
Statement from Susan G. Komen for the Cure Board of Directors and Founder and CEO Nancy G. Brinker
2/3/2012
More...
|
ISCTM Pushes for Innovation in the Development of Novel Therapies for CNS Disorders
2/3/2012
More...
|
Covidien (COV) Release: Results from Solitaire with the Intention for Thrombectomy (SWIFT) Study Announced at the International Stroke Conference on February 3
2/3/2012
More...
|
Histogenics Corporation to Present at Canaccord Adams Genuity Musculoskeletal Conference
2/3/2012
More...
|
Incyte Corporation (INCY) to Present at the Leerink Swann and Company 2012 Global Healthcare Conference
2/3/2012
More...
|
SAFE-BioPharma, LLC Standard to be Highlighted at Molecular TriCon
2/3/2012
More...
|